U S Physical Therapy Inc (USPH): EBITDA
$109.07M
Year ended 2025-12-31
$98.93M
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $109.07M | +33.5% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $81.67M | +23.4% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $66.21M | n/c | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $71.54M | -13.0% | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | $82.24M | +30.7% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $62.95M | -18.8% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $77.52M | +10.6% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $70.07M | +8.7% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $64.44M | +10.5% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $58.31M | +5.5% | 2019-03-18, From 2016-01-01 |
| 2015-12-31 | $55.25M | +5.2% | 2018-03-14, From 2015-01-01 |
| 2014-12-31 | $52.51M | +18.4% | 2017-06-07, From 2014-01-01 |
| 2013-12-31 | $44.33M | +1.5% | 2016-03-04, From 2013-01-01 |
| 2012-12-31 | $43.69M | +18.5% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $36.88M | n/c | 2014-03-11, From 2011-01-01 |
| 2010-12-31 | $38.86M | +13.8% | 2013-03-12, From 2010-01-01 |
| 2009-12-31 | $34.15M | n/a | 2012-03-09, From 2009-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $109.07M | +33.5% |
| Pennant Group, Inc. (PNTG) | 2025-12-31 | $60.42M | +36.6% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $23.76M | n/m |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $65.77M | +625.6% |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | -$3.48M | n/m |
| P3 Health Partners Inc. (PIII) | 2025-12-31 | -$186.14M | n/m |
| DocGo Inc. (DCGO) | 2025-12-31 | -$162.37M | n/m |
| Privia Health Group, Inc. (PRVA) | 2025-12-31 | $44.14M | +82.0% |
| Omada Health, Inc. (OMDA) | 2025-12-31 | -$6.48M | n/m |
Compare USPH, PNTG, INNV, LFST side by side · Screen every company in Services-Health Services ↗